David Kuter, MD, DPhil discusses Wayrilz™ (rilzabrutinib), a new FDA-approved treatment for persistent or chronic immune thrombocytopenia (ITP). Dr Kuter ...

Capvaxive was approved in 2024 for the prevention of invasive pneumococcal disease and pneumococcal pneumonia caused by Streptococcus pneumoniae in adults.

HealthDay News — The US Food and Drug Administration released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.

No adverse neurodevelopmental effects with addition of dexmedetomidine and remifentanil to sevoflurane anesthesia.

HealthDay News — A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder (GAD), according to a study ...

The Food and Drug Administration (FDA) has approved Koselugo (selumetinib) oral granules and capsules for pediatric patients aged 1 year and older with neurofibromatosis type 1 (NF1) who have ...

The decline in matriculants who are underrepresented in medicine “may have significant and long-lasting implications for racial and ethnic diversity in the physician workforce,” researchers concluded.

Previously in 2021, the FDA issued a safety communication regarding 25 cases of serious liver injury in Ocaliva-treated PBC patients with either compensated or decompensated cirrhosis.

SAR402663 is an investigational one-time intravitreal gene therapy that delivers genetic material encoding soluble FLT01.

Study results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions,” researchers wrote.

Chagas disease — a potentially serious illness spread by an insect called the “kissing bug” — may be establishing itself in the US, according to a new US Centers for Disease Control and Prevention ...

Written by researchers for the US Department of Health and Human Services (HHS), the Alcohol Intake and Health Study warned that even one drink a day boosts the risk of liver cirrhosis, oral and ...